Peripheral Artery Disease Market Size, Share, Growth Analysis, By Product Type(Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters), By Route of Administration(Oral, Parenteral, Others), By End Users(Hospitals & Clinics, Ambulatory Surgical Clinics, Others), By Region - Industry Forecast 2024-2031

Drivers

Rise in the Elderly Population

• The escalating number of elderly individuals grappling with diabetes and hypertension stands out as a significant risk factor contributing to the surge in peripheral artery disease (PAD), thereby fueling the market. Geriatric populations are particularly susceptible to the development of vascular complications, with diabetes and high blood pressure exacerbating the risk. These chronic conditions often lead to the narrowing and hardening of arteries, diminishing blood flow to the extremities and increasing the likelihood of PAD.

Restraints

Concerns Regarding Product Recalls

• The anticipated recurrence of peripheral artery disease (PAD) even post-treatment is poised to be a significant obstacle in the growth trajectory of the peripheral arterial disease market during the forecast period. Despite advancements in medical interventions, the likelihood of PAD reoccurrence poses a challenge to sustained market expansion. Additionally, concerns regarding product recalls within the industry may further compound challenges for the peripheral arterial disease market in the near future. Product recalls can impact consumer confidence, create regulatory scrutiny, and necessitate corrective measures, all of which may impede the overall growth and stability of the PAD market. Navigating these challenges will require a concerted effort from stakeholders to address the complexities associated with disease management and product safety, ensuring the sustained development of effective solutions in the field of peripheral arterial disease.